DNTH
DNTH
NASDAQ · Biotechnology

Dianthus Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$95.26
-1.55 (-1.60%)
As of Sep 21, 1:40 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 21 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -59.2% upside
Low Target $27.89
Average Target $38.82
High Target $53.79
Current Price $95.26
Current
$95.26
Target
$38.82
$27.89 $38.82 avg $53.79
Scenario Analysis
Bear Case
$27.89
-70.7%
Low target
Base Case
$38.82
-59.2%
Avg target
Bull Case
$53.79
+-43.5%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$117.88
-19.2% from high
52-Week Low
$32.22
+195.7% from low
50-Day SMA
$45.37
+110.0% vs SMA
200-Day SMA
$31.95
+198.2% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$38.82
-67.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%